Literature DB >> 21037117

Lobular involution, mammographic density, and breast cancer risk: visualizing the future?

Gretchen L Gierach, Louise A Brinton, Mark E Sherman.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21037117      PMCID： PMC2982811          DOI： 10.1093/jnci/djq433

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  19 in total

1.  Mammographic breast density as a general marker of breast cancer risk.

Authors:  Celine M Vachon; Kathleen R Brandt; Karthik Ghosh; Christopher G Scott; Shaun D Maloney; Michael J Carston; V Shane Pankratz; Thomas A Sellers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-01       Impact factor: 4.254

2.  Age-related lobular involution and risk of breast cancer.

Authors:  Tia R Milanese; Lynn C Hartmann; Thomas A Sellers; Marlene H Frost; Robert A Vierkant; Shaun D Maloney; V Shane Pankratz; Amy C Degnim; Celine M Vachon; Carol A Reynolds; Romayne A Thompson; L Joseph Melton; Ellen L Goode; Daniel W Visscher
Journal:  J Natl Cancer Inst       Date:  2006-11-15       Impact factor: 13.506

3.  Mammographic density and estrogen receptor status of breast cancer.

Authors:  Elad Ziv; Jeffrey Tice; Rebecca Smith-Bindman; John Shepherd; Steven Cummings; Karla Kerlikowske
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-12       Impact factor: 4.254

4.  Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database.

Authors:  William F Anderson; Nilanjan Chatterjee; William B Ershler; Otis W Brawley
Journal:  Breast Cancer Res Treat       Date:  2002-11       Impact factor: 4.872

5.  Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis.

Authors:  Valerie A McCormack; Isabel dos Santos Silva
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-06       Impact factor: 4.254

Review 6.  Developmental, cellular, and molecular basis of human breast cancer.

Authors:  J Russo; Y F Hu; X Yang; I H Russo
Journal:  J Natl Cancer Inst Monogr       Date:  2000

Review 7.  Morphogens, morphostats, microarchitecture and malignancy.

Authors:  John D Potter
Journal:  Nat Rev Cancer       Date:  2007-06       Impact factor: 60.716

8.  Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer.

Authors:  Huiyan Ma; Jianning Luo; Michael F Press; Yaping Wang; Leslie Bernstein; Giske Ursin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

Review 9.  Mammographic density, lobular involution, and risk of breast cancer.

Authors:  O M Ginsburg; L J Martin; N F Boyd
Journal:  Br J Cancer       Date:  2008-09-09       Impact factor: 7.640

Review 10.  Mammographic density. Measurement of mammographic density.

Authors:  Martin J Yaffe
Journal:  Breast Cancer Res       Date:  2008-06-19       Impact factor: 6.466
View more
  3 in total

1.  The relationship between terminal duct lobular unit features and mammographic density among Chinese breast cancer patients.

Authors:  Hyuna Sung; Changyuan Guo; Erni Li; Jing Li; Ruth M Pfeiffer; Jennifer L Guida; Renata Cora; Nan Hu; Joseph Deng; Jonine D Figueroa; Mark E Sherman; Gretchen L Gierach; Ning Lu; Xiaohong R Yang
Journal:  Int J Cancer       Date:  2019-01-07       Impact factor: 7.396

2.  Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study.

Authors:  Jonine D Figueroa; Ruth M Pfeiffer; Louise A Brinton; Maya M Palakal; Amy C Degnim; Derek Radisky; Lynn C Hartmann; Marlene H Frost; Melody L Stallings Mann; Daphne Papathomas; Gretchen L Gierach; Stephen M Hewitt; Maire A Duggan; Daniel Visscher; Mark E Sherman
Journal:  Breast Cancer Res Treat       Date:  2016-08-03       Impact factor: 4.872

3.  68Ga-FAPI-PET/CT in patients with various gynecological malignancies.

Authors:  Katharina Dendl; Stefan A Koerber; Rebecca Finck; Kgomotso M G Mokoala; Fabian Staudinger; Lisa Schillings; Ulrike Heger; Manuel Röhrich; Clemens Kratochwil; Mike Sathekge; Dirk Jäger; Jürgen Debus; Uwe Haberkorn; Frederik L Giesel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-29       Impact factor: 10.057
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.